Back to Market Feed

Product Information

SKYRIZI 150 MG/ML PEN is a brand product labeled by AbbVie Inc., priced at $22761.4629 per ML under NDC 00074210001. Its NADAC has been published 196 times since Nov 23, 2022.

SKYRIZI 150 MG/ML PEN

risankizumab-rzaa
$22761.4629per ML

Strength

150 mg/mL

Manufacturer

AbbVie Inc.

NDC

00074210001

Classification

Brand

Dosage Form

INJECTION

Route

SUBCUTANEOUS

Effective Date

8/19/2026

Active Ingredients

RISANKIZUMAB

Approval Type

Biologic (BLA)

FDA Application

BLA761105

On Market Since

4/26/2021

Pharmacological Classes

Interleukin-23 Antagonist
Interleukin-23 Antagonists

Price Statistics

The NADAC for SKYRIZI 150 MG/ML PEN has been published 196 times since Nov 23, 2022, and over the history we have for it it has risen 28.6%. The table below summarizes its recorded NADAC range and movement.

Current price$22761.4629 per ML
All-time high$22807.6858 (May 13, 2026)
All-time low$17642.3820 (Dec 21, 2022)
52-week high$22807.6858
52-week low$21408.4649
Median price$20292.2678
Average price$20585.8463
Largest weekly change+8.0% (Jan 11, 2023)
Weeks tracked196
Tracking sinceNov 23, 2022

Price History

1W

+0.1%

1M

+0.1%

3M

+0.1%

6M

-0.2%

1Y

+6.1%

3Y

+19.5%

5Y

N/A

All

+28.6%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

SKYRIZI 150 MG/ML SYRINGE
Brand
00074105001•AbbVie Inc.
$22887.4386
+1% more

Related Drugs

Same classification

TREMFYA 200 MG/2 ML PEN
Brand
57894065102•Janssen Biotech, Inc.
$7318.9883
per ML
TREMFYA 100 MG/ML SYRINGE
Brand
57894064001•Janssen Biotech, Inc.
$14728.9053
per ML
TREMFYA 100 MG/ML ONE-PRESS
Brand
57894064011•Janssen Biotech, Inc.
$14745.8421
per ML
STELARA 90 MG/ML SYRINGE
Brand
57894006103•Janssen Biotech, Inc.
$29792.7867
per ML
STELARA 45 MG/0.5 ML SYRINGE
Brand
57894006003•Janssen Biotech, Inc.
$29874.4480
per ML

Frequently asked questions

What is the NADAC price of SKYRIZI 150 MG/ML PEN?

The current National Average Drug Acquisition Cost (NADAC) for SKYRIZI 150 MG/ML PEN, manufactured by AbbVie Inc., is $22761.4629 per ML (NDC 00074210001), effective Aug 19, 2026.

How has the price of SKYRIZI 150 MG/ML PEN changed over time?

Over the history we have for it, the NADAC for SKYRIZI 150 MG/ML PEN has risen 28.6%. It has been tracked across 196 weekly CMS publications since Nov 23, 2022.

What are the highest and lowest recorded NADAC prices for SKYRIZI 150 MG/ML PEN?

Since Nov 23, 2022, the NADAC for SKYRIZI 150 MG/ML PEN has ranged from a low of $17642.3820 (Dec 21, 2022) to a high of $22807.6858 (May 13, 2026), with a median of $20292.2678 per ML.

Are there cheaper alternatives to SKYRIZI 150 MG/ML PEN?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as SKYRIZI 150 MG/ML PEN in a comparable dosage form, but none are currently priced below it.

Who manufactures SKYRIZI 150 MG/ML PEN?

SKYRIZI 150 MG/ML PEN (NDC 00074210001) is labeled by AbbVie Inc., and CMS classifies it as a brand product.